Biblio
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Oncogene. 2019.
Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity. Pharmacol Res. 2020:104955.
Integrated proteomic and Phosphoproteomic analysis for characterization of colorectal cancer. J Proteomics. 2022:104808.